Apoptosis inducer 13

• UNSPSC Description:

  Apoptosis inducer 13 (Compound Ru4) can induce cancer cell apoptosis, and inhibits cancer cell migration and invasion. Apoptosis inducer 13 converts coenzyme NADH to NAD+, and increases intracellular ROS levels[1].

• Target Antigen:

  Apoptosis; Reactive Oxygen Species

• Type:

  Reference compound

• Related Pathways:

  Apoptosis;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/apoptosis-inducer-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  F[P-](F)(F)(F)(F)F.Cc1c(C)c(C)c(C)c(C)c1C.O=C(C2=C3C(C4=C(NC(C5=CC=CC=C5)(C6=CC=CC=C6)N7)C7=C38)=C(C(N(CCCC)C4=O)=O)C9=C2N=C%10C(C%11=CC=C[N]%12=C%11C(C%10=CC=C%13)=[N]%13[Ru+]%12(Cl)[])=N9)N(CCCC)C8=O

• Molecular Weight:

  1220.60

• References & Citations:

  [1]Yang Y, et al. Naphthalene Diimide-Functionalized Half-Sandwich Ru(II) Complexes as Mitochondria-Targeted Anticancer and Antimetastatic Agents. Inorg Chem. 2023 Jun 19;62(24):9649-9660.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported